BRPI0406801B8 - derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes - Google Patents

derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes

Info

Publication number
BRPI0406801B8
BRPI0406801B8 BRPI0406801A BRPI0406801A BRPI0406801B8 BR PI0406801 B8 BRPI0406801 B8 BR PI0406801B8 BR PI0406801 A BRPI0406801 A BR PI0406801A BR PI0406801 A BRPI0406801 A BR PI0406801A BR PI0406801 B8 BRPI0406801 B8 BR PI0406801B8
Authority
BR
Brazil
Prior art keywords
thieno
modulation
autoimmune diseases
sup
pyrimidinedione derivatives
Prior art date
Application number
BRPI0406801A
Other languages
English (en)
Inventor
Simon David Guile
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BRPI0406801A publication Critical patent/BRPI0406801A/pt
Publication of BRPI0406801B1 publication Critical patent/BRPI0406801B1/pt
Publication of BRPI0406801B8 publication Critical patent/BRPI0406801B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Abstract

"derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes". a presente invenção se refere a derivados de tieno-pirimidinodiona de fórmula (1): em que r^ 1^ e r^ 2^ independentemente entre si, representam um grupo c~ 1-6~alquila, c~ 3-6~alquenila, c~ 3-5~cicloalquil-c~ 1-3~alquila ou c~ 3-6~cicloalquila; cada um dos quais podendo ser opcionalmente substituído por 1 a 3 átomos de halogênio; r^ 3^ é um grupo- co-g ou so~ 2~-g, onde g é um anel de 5 ou 6 membros contendo um átomo de nitrogênio e um segundo heteroátomo selecionado de oxigênio e enxofre adjacente ao nitrogênio; o anel sendo substituído por pelo menos um grupo conforme definido no relatório descritivo; q é cr^ 4^r^ 5^, onde r^ 4^ é hidrogênio, flúor ou c~ 1-6~ alquila e r^ 5^ é hidrogênio, flúor ou hidróxi; e ar é um sistema de anel aromático de 5 a 10 membros, em que até 4 átomos do anel podem ser heteroátomos, independentemente selecionados de nitrogênio, oxigênio e enxofre, o sistema de anel sendo opcionalmente substituído por um ou mais grupos definidos no presente relatório descritivo; assim como sais e solvatos farmaceuticamente aceitáveis do mesmo. são também descritos processos para a preparação de tais compostos, composições farmacêuticas contendo os mesmos e seu uso em procedimentos de terapia, particularmente, na terapia de imunossupressão.
BRPI0406801A 2003-01-17 2004-01-15 derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes BRPI0406801B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0300119A SE0300119D0 (sv) 2003-01-17 2003-01-17 Novel compounds
SE0300119-5 2003-01-17
PCT/SE2004/000052 WO2004065394A1 (en) 2003-01-17 2004-01-15 Thienopyrimidinediones and their use in the modulation of autoimmune disease

Publications (3)

Publication Number Publication Date
BRPI0406801A BRPI0406801A (pt) 2006-01-17
BRPI0406801B1 BRPI0406801B1 (pt) 2018-04-03
BRPI0406801B8 true BRPI0406801B8 (pt) 2021-05-25

Family

ID=20290154

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0406801A BRPI0406801B8 (pt) 2003-01-17 2004-01-15 derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes

Country Status (24)

Country Link
US (2) US7384951B2 (pt)
EP (1) EP1587812B1 (pt)
JP (1) JP4519121B2 (pt)
KR (2) KR101107486B1 (pt)
CN (1) CN100334093C (pt)
AT (1) ATE335748T1 (pt)
AU (1) AU2004206012B2 (pt)
BR (1) BRPI0406801B8 (pt)
CA (1) CA2512441C (pt)
DE (1) DE602004001857T2 (pt)
EG (1) EG25613A (pt)
ES (1) ES2270337T3 (pt)
HK (1) HK1081959A1 (pt)
IL (1) IL169370A (pt)
IS (1) IS2376B (pt)
MX (1) MXPA05007496A (pt)
NO (1) NO333702B1 (pt)
NZ (1) NZ541217A (pt)
PL (1) PL214682B1 (pt)
RU (1) RU2331647C2 (pt)
SE (1) SE0300119D0 (pt)
UA (1) UA81788C2 (pt)
WO (1) WO2004065394A1 (pt)
ZA (1) ZA200505364B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117583D0 (en) * 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
GB0118479D0 (en) * 2001-07-28 2001-09-19 Astrazeneca Ab Novel compounds
PL378221A1 (pl) * 2003-01-17 2006-03-20 Astrazeneca Ab Tienopirydazynony i ich zastosowanie w modulacji choroby autoimmunologicznej
SE0300120D0 (sv) * 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds
AU2004308299B2 (en) 2003-12-19 2011-11-24 Plexxikon, Inc. Compounds and methods for development of Ret modulators
US7498342B2 (en) 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
BRPI0610066A2 (pt) 2005-05-17 2010-05-25 Plexxikon Inc compostos que modulam atividade de c-kit e c-fms e usos para estes
EP2395004B1 (en) 2005-06-22 2016-01-20 Plexxikon Inc. Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
PE20121126A1 (es) 2006-12-21 2012-08-24 Plexxikon Inc Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
WO2008079909A1 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
BRPI0720695A2 (pt) 2006-12-21 2014-02-18 Plexxikon Inc Compostos e métodos para modulação de cinase, e indicações para estes
GB0713479D0 (en) * 2007-07-11 2007-08-22 Syngenta Participations Ag Substituted aromatic heterocyclic compounds as fungicides
BRPI0814423B1 (pt) 2007-07-17 2022-04-19 Plexxikon, Inc Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
WO2010089580A1 (en) 2009-02-06 2010-08-12 Astrazeneca Ab Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4
KR20120001746A (ko) * 2009-03-23 2012-01-04 그렌마크 파머수티칼스 에스. 아. Ｔｒｐａ1 조절자로서 이소티아졸로-피리미딘디온 유도체
PL2411395T3 (pl) * 2009-03-23 2013-10-31 Glenmark Pharmaceuticals Sa Pochodne furopirymidynodionu jako modulatory TRPA1
AU2010232670B2 (en) 2009-04-03 2015-07-09 F. Hoffmann-La Roche Ag Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
BR112012012156A2 (pt) 2009-11-06 2015-09-08 Plexxikon Inc compostos e métodos para modulação de cinase, e indicações para esta
BR112013020041B1 (pt) 2011-02-07 2021-11-23 Plexxikon, Inc Compostos e composições para a modulação de quinases e uso dos mesmos
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9296728B2 (en) 2012-01-20 2016-03-29 Regents Of The University Of Minnesota Therapeutic compounds
GB2523211B (en) 2012-01-27 2020-03-18 Univ Jefferson MCT protein inhibitor-related prognostic and therapeutic methods
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US10022372B2 (en) 2013-04-19 2018-07-17 Thomas Jefferson University Caveolin-1 related methods for treating glioblastoma with temozolomide
KR102228034B1 (ko) * 2013-10-21 2021-03-16 제노스코 치환된 피리미딘 화합물 및 syk 억제제로서의 이의 용도
US10329303B2 (en) * 2015-01-22 2019-06-25 The Scripps Research Institute Heterocyclic inhibitors of monocarboxylate transporter
UY36586A (es) * 2015-03-26 2016-10-31 Bayer Pharma AG Heterociclilmetiltienouracilos y uso de los mismos
KR101712836B1 (ko) * 2016-03-17 2017-03-22 주식회사 골프존 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체
KR101712838B1 (ko) * 2016-03-17 2017-03-07 주식회사 골프존 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체
KR101730536B1 (ko) * 2016-03-17 2017-05-02 주식회사 골프존 스크린 골프 시스템에서 구현되는 컨텐츠 전송 서비스 방법, 컨텐츠 전송 서비스를 위한 모바일 단말기의 제어방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록매체
TWI823932B (zh) 2018-05-11 2023-12-01 中國大陸商迪哲（江蘇）醫藥有限公司 三唑并嘧啶化合物及其在治療癌症中之用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US738495A (en) * 1902-12-26 1903-09-08 William E Sherwood Thill-coupling.
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
US6469014B1 (en) * 1997-05-28 2002-10-22 Astrazeneca Ab Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
PL340836A1 (en) 1997-12-05 2001-02-26 Astrazeneca Uk Ltd Novel compounds
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
WO2000012514A1 (en) 1998-08-28 2000-03-09 Astrazeneca Ab Novel compounds
DE60104677T2 (de) * 2000-05-04 2005-07-28 Astrazeneca Ab THIENO[2,3-d]PYRIMIDINDIONE UND IHRE VERWENDUNG ALS PHARMAZEUTISCHE MITTEL
GB0117583D0 (en) * 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
GB0118479D0 (en) * 2001-07-28 2001-09-19 Astrazeneca Ab Novel compounds
PL378221A1 (pl) 2003-01-17 2006-03-20 Astrazeneca Ab Tienopirydazynony i ich zastosowanie w modulacji choroby autoimmunologicznej
SE0300120D0 (sv) 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
PL214682B1 (pl) 2013-09-30
PL378222A1 (pl) 2006-03-20
US7384951B2 (en) 2008-06-10
IS7965A (is) 2005-07-29
DE602004001857D1 (de) 2006-09-21
AU2004206012A1 (en) 2004-08-05
CN100334093C (zh) 2007-08-29
IL169370A (en) 2011-05-31
NO20053826D0 (no) 2005-08-15
IL169370A0 (en) 2007-07-04
US20080214579A1 (en) 2008-09-04
CA2512441A1 (en) 2004-08-05
SE0300119D0 (sv) 2003-01-17
WO2004065394A1 (en) 2004-08-05
RU2005121494A (ru) 2006-02-10
AU2004206012B2 (en) 2007-06-14
JP4519121B2 (ja) 2010-08-04
KR20050092760A (ko) 2005-09-22
JP2006516974A (ja) 2006-07-13
NZ541217A (en) 2008-05-30
NO333702B1 (no) 2013-08-26
RU2331647C2 (ru) 2008-08-20
CA2512441C (en) 2012-01-03
EP1587812B1 (en) 2006-08-09
BRPI0406801A (pt) 2006-01-17
KR101107486B1 (ko) 2012-01-19
NO20053826L (no) 2005-10-17
ES2270337T3 (es) 2007-04-01
DE602004001857T2 (de) 2007-05-24
US20060052400A1 (en) 2006-03-09
EP1587812A1 (en) 2005-10-26
ZA200505364B (en) 2006-09-27
MXPA05007496A (es) 2005-09-21
EG25613A (en) 2012-03-22
IS2376B (is) 2008-07-15
HK1081959A1 (en) 2006-05-26
KR20110125256A (ko) 2011-11-18
UA81788C2 (uk) 2008-02-11
ATE335748T1 (de) 2006-09-15
CN1761672A (zh) 2006-04-19
BRPI0406801B1 (pt) 2018-04-03

Similar Documents

Publication Publication Date Title
BRPI0406801B8 (pt) derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes
PT1263724E (pt) Novos compostos
IS6658A (is) Ný efnasambönd
SE9902987D0 (sv) Novel compounds
SE0302139D0 (sv) Novel compounds
EA200401526A1 (ru) Новые соединения и их применение
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
ATE316083T1 (de) Adamantanderivate
AU2003228770A1 (en) Substituted pyrazolopyrimidines
ES2328496T3 (es) Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos.
DE60301339D1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
SE0101038D0 (sv) Novel compounds
GB0120461D0 (en) Novel compounds
SE0303280D0 (sv) Novel compounds
IL172538A0 (en) Depsipeptide compounds, pharmaceutical compositions containing the same and processes for the preparation thereof
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
SE0302755D0 (sv) Novel compounds
ATE274515T1 (de) Pyrazolopyridinderivate
SE0202693D0 (sv) Compounds
SE0403118D0 (sv) New compounds 2
MXPA05007495A (es) Tienopiridazinonas y su uso en la modulacion de enfermedades autoinmunes.
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
SE0403117D0 (sv) New compounds 1
SE0002330D0 (sv) Novel compounds
SE0004480D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06J Correction of requirement [chapter 6.10 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/01/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2653 DE 09-11-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.